Risk-Characterization Framework for Decision-Making at the Food and Drug Administration
Work detail
Bookitis PickRF
Risk-Characterization Framework for Decision-Making at the Food and Drug Admi...
Phase II Committee on Ranking FDA Product Categories Based on Health ConsequencesInstitute of MedicineBoard on Environmental Studies and ToxicologyDivision on Earth and Life StudiesNational Research Council3 editions
This page groups all known editions belonging to the same underlying work.
Overview
Shared work-level identity and catalog context.
5 credited authorsSearch language english
Contributors
People credited with this work in the active catalog.
- Open Author
Phase II Committee on Ranking FDA Product Categories Based on Health Consequences
- Open Author
Institute of Medicine
- Open Author
Board on Environmental Studies and Toxicology
- Open Author
Division on Earth and Life Studies
- Open Author
National Research Council
Editions
Publication-specific versions linked to this work only.
- RFRisk-Characterization Framework...Institute of Medicine, National Research Council, Division on Earth and Life Studies, Board on Environmental Studies and Toxicology, Phase II Committee on Ranking FDA Product Categories Based on Health Consequences
Risk-Characterization Framework for Decision-Making at the Food and Drug Administration
- RFRisk-Characterization Framework...Phase II Committee on Ranking FDA Product Categories Based on Health Consequences, Board on Environmental Studies and Toxicology, Institute of Medicine, Division on Earth and Life Studies, National Research Council
Risk-Characterization Framework for Decision-Making at the Food and Drug Administration
- RFRisk-Characterization Framework...Institute of Medicine, National Research Council, Division on Earth and Life Studies, Board on Environmental Studies and Toxicology, Phase II Committee on Ranking FDA Product Categories Based on Health Consequences
Risk-Characterization Framework for Decision-Making at the Food and Drug Administration